Inventor
ZELDIS JEROME B
US63 patents
⚠️ This page may combine multiple inventors who share the name “ZELDIS JEROME B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
37 patentsUS9101622B2Aug 11, 2015
Methods for treating newly diagnosed multiple myeloma 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone
CELGENE CORP60 citations99
US9101621B2Aug 11, 2015
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
CELGENE CORP744 citations99
US8673939B2Mar 18, 2014
Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
CELGENE CORP41 citations99
US7968569B2Jun 28, 2011
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
CELGENE CORP87 citations99
US7468363B2Dec 23, 2008
Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
CELGENE CORP79 citations99
US7393862B2Jul 1, 2008
Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
CELGENE CORP100 citations99
US7189740B2Mar 13, 2007
Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
CELGENE CORP137 citations99
US8735428B2May 27, 2014
Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
CELGENE CORP37 citations98
US8759375B2Jun 24, 2014
Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with proteasome inhibitor
CELGENE CORP18 citations96
US8530498B1Sep 10, 2013
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione
CELGENE CORP32 citations96
US7863297B2Jan 4, 2011
Methods of using 4-(amino)-2-(2,6-dioxo(3-piperidly))-isoindoline-3-dione for the treatment of myelodysplastic syndromes
CELGENE CORP41 citations96
US6255325B1Jul 3, 2001
Chronic, bolus administration of D-threo methylphenidate
CELGENE CORP53 citations96
US9056120B2Jun 16, 2015
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
CELGENE CORP19 citations93
US9050324B2Jun 9, 2015
Methods for treating amyloidosis with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
CELGENE CORP6 citations93
US8722705B2May 13, 2014
Methods for treating diffuse large B-cell lymphoma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
CELGENE CORP7 citations93
US7563810B2Jul 21, 2009
Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
CELGENE CORP17 citations93
US7393863B2Jul 1, 2008
Methods of using N-{[2-(2,6-dioxo(3-piperidyl)-1,3-dioxoisoindolin-4-yl]methyl}cyclopropyl-carboxamide for the treatment and management of myelodysplastic syndromes
CELGENE CORP30 citations93
US7323479B2Jan 29, 2008
Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
CELGENE CORP36 citations93
US7182953B2Feb 27, 2007
Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
CELGENE CORP14 citations93
US6602887B2Aug 5, 2003
Chronic, bolus administration of D-threo methylphenidate
CELGENE CORP28 citations92
US6486177B2Nov 26, 2002
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
CELGENE CORP31 citations92
US5922736AJul 13, 1999
Chronic, bolus administration of D-threo methylphenidate
CELGENE CORP34 citations92
US7115631B2Oct 3, 2006
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
CELGENE CORP39 citations90
US9498472B2Nov 22, 2016
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
CELGENE CORP3 citations84
US9393238B2Jul 19, 2016
Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
CELGENE CORP3 citations84
US9056103B2Jun 16, 2015
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
CELGENE CORP7 citations84
US8623384B2Jan 7, 2014
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of acute myelogenous leukemia
CELGENE CORP9 citations84
US7612096B2Nov 3, 2009
Methods for treatment, modification and management of radiculopathy using 1-oxo-2-(2,6-dioxopiperidin-3yl)-4-aminoisoindoline
CELGENE CORP9 citations79
US7435726B2Oct 14, 2008
Compositions and methods for the treatment of cancer
CELGENE CORP14 citations79
US9155730B2Oct 13, 2015
Methods for treating non-hodgkin's lymphoma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a second active agent
CELGENE CORP3 citations74
US7325355B2Feb 5, 2008
Methods for treatment of atherosclerosis using 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline
CELGENE CORP7 citations74
USRE48890EJan 11, 2022
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
CELGENE CORP0 citations63
US11116782B2Sep 14, 2021
Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
CELGENE CORP0 citations63
US10206914B2Feb 19, 2019
Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
CELGENE CORP0 citations63
US9925207B2Mar 27, 2018
Methods of treating myelodysplastic syndromes using lenalidomide
CELGENE CORP1 citations63
US9662321B2May 30, 2017
Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents
CELGENE CORP0 citations63
US9283215B2Mar 15, 2016
Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione in combination with antibodies
CELGENE CORP0 citations63
ZELDIS JEROME B
12 patentsUS8198306B2Jun 12, 2012
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with a proteasome inhibitor
ZELDIS JEROME B54 citations99
US8198262B2Jun 12, 2012
Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
ZELDIS JEROME B65 citations99
US8648095B2Feb 11, 2014
Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
ZELDIS JEROME B32 citations98
US8722647B2May 13, 2014
Methods for treating amyloidosis using 4-(amino)-2-(2,6-Dioxo(3-piperidyl))- isoindoline-1,3-dione
ZELDIS JEROME B14 citations96
US8207200B2Jun 26, 2012
Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroindol-2-yl)-piperidine-2,6-dione follow by autologous stem cell transplantation
ZELDIS JEROME B28 citations96
US8188118B2May 29, 2012
Method for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with antibodies
ZELDIS JEROME B34 citations96
US8741929B2Jun 3, 2014
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of mantle cell lymphomas
ZELDIS JEROME B21 citations93
US8492406B2Jul 23, 2013
Methods for treatment of follicular lymphoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
ZELDIS JEROME B10 citations93
US8410136B2Apr 2, 2013
Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
ZELDIS JEROME B9 citations93
US8632787B2Jan 21, 2014
Methods using immunomodulatory compounds for treatment of certain leukemias
ZELDIS JEROME B8 citations84
US8440194B2May 14, 2013
Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
ZELDIS JEROME B9 citations84
US8404717B2Mar 26, 2013
Methods of treating myelodysplastic syndromes using lenalidomide
ZELDIS JEROME B6 citations73
THERAKOS INC
1 patentShowing the top 50 of 63 patents by PatentIndex Score.